Autopsy report · NCT01122342

Vaginal Testosterone Cream For Atrophic Vaginitis in Women Taking Aromatase Inhibitors for Breast Cancer.

“Evaluating outcomes of current subjects pre further enrollment/dose reduction.”

The sponsor’s own words in the registry.

Life of this trial

• Registered 3 years 5 months after it had already started.
• Suspended: paused, and may or may not restart.
• 30 participants planned (an estimate, not an actual count).

Vital statistics

Status

Suspended

Phase

Phase 1, Phase 2

Sponsor

University of Vermont

Sponsor type

University, hospital or other

Conditions

Vaginitis; Dyspareunia; Breast Neoplasms

Interventions

Testosterone propionate

Participants

30 (planned, not actual)

Sites

2

Countries

United States

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.